Type ? Trade names Anthim CAS Number 1351337-07-9 | ATC code none | |
 | ||
Target | ||
Obiltoxaximab is a monoclonal antibody designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).
This drug was developed by Elusys Therapeutics, Inc.
References
Obiltoxaximab Wikipedia(Text) CC BY-SA